TRIPALMITIN

TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.

Cross Reference

Introduction

To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with TRIPALMITIN?

TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with TRIPALMITIN

MeSH term MeSH ID Detail
Leishmaniasis, Visceral D007898 13 associated lipids
Respiratory Distress Syndrome, Newborn D012127 5 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
HIV-Associated Lipodystrophy Syndrome D039682 3 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with TRIPALMITIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with TRIPALMITIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with TRIPALMITIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with TRIPALMITIN?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with TRIPALMITIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with TRIPALMITIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with TRIPALMITIN

Download all related citations
Per page 10 20 50 100 | Total 272
Authors Title Published Journal PubMed Link
Schmiele M et al. Formation of liquid crystalline phases in aqueous suspensions of platelet-like tripalmitin nanoparticles. 2014 J Chem Phys pmid:24908039
Hazotte A et al. High-temperature micro liquid chromatography for lipid molecular species analysis with evaporative light scattering detection. 2007 J Chromatogr A pmid:17161844
Gaudin K et al. Adaptation of an evaporative light-scattering detector to micro and capillary liquid chromatography and response assessment. 2004 J Chromatogr A pmid:15532554
Holčapek M et al. Regioisomeric analysis of triacylglycerols using silver-ion liquid chromatography-atmospheric pressure chemical ionization mass spectrometry: comparison of five different mass analyzers. 2010 J Chromatogr A pmid:21075380
Müller M et al. Development of solvent systems with room temperature ionic liquids for the countercurrent chromatographic separation of very nonpolar lipid compounds. 2017 J Chromatogr A pmid:28179081
Helgason T et al. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). 2009 J Colloid Interface Sci pmid:19380149
Garcia-Fuentes M et al. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. 2005 J Colloid Interface Sci pmid:15837476
Tikka HK et al. Soiling of pure PVC studied by FTIR, optical microscopy, and AFM. 2004 J Colloid Interface Sci pmid:15082372
Windbergs M et al. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures. 2009 J Control Release pmid:19358867
Tosi A et al. Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications. 2006 J Control Release pmid:17718971
Vitorino C et al. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. 2013 J Control Release pmid:23454133
Bunjes H and Koch MH Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. 2005 J Control Release pmid:16023752
Manjunath K and Venkateswarlu V Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. 2005 J Control Release pmid:16014318
Venkateswarlu V and Manjunath K Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. 2004 J Control Release pmid:15023472
Severino P et al. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. 2012 J Drug Deliv pmid:22175030
Manjunath K and Venkateswarlu V Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. 2006 J Drug Target pmid:17090399
Pal A et al. Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. 2012 J Liposome Res pmid:21740098
Potta SG et al. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. 2011 J Microencapsul pmid:21171818
Ucisik MH et al. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. 2013 J Nanobiotechnology pmid:24314310
Yoshikawa S et al. Promotional effects of new types of additives on fat crystallization. 2014 J Oleo Sci pmid:24599107